Nixon Peabody has named Seth Mailhot the new leader of the FDA regulatory practice in the firm's Washington, D.C., office, the firm announced today. He'll also be a member of the firm's life sciences and health services practices.
Mailhot, 37, joins the firm as counsel. He spent 14 years
with the Food and Drug Administration as a certified medical device
investigator, an engineer and a compliance officer. Most recently, he was an
associate at Latham & Watkins, also specializing in food-and-drug law.
Mailhot has concentrated on international regulatory issues,
particularly in China and Europe. He said a chief goal in his new post is to
build up the international food-and-drug practice at Nixon Peabody, which
already has offices in Europe and Asia. “I've been given the go-ahead to build
things out as I see fit,” he said.
Nixon Peabody partner Susan Robfogel, head of the firm’s
life sciences practice, said Mailhot’s international experience was a major
factor in his hiring, especially considering the number of FDA regulatory cases
coming out of China recently.
“What Seth helps us do is add depth to the FDA practice,”
Robfogel said. “In part, we look forward to the enhancement of the Chinese and
European practices that he might bring.”
Comments